Neuropeptides collaborate with conventional neurotransmitters to regulate synaptic output.
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METHODS
Cell Culture. Neuronal cultures were prepared from embryonic day 8 (E8) ciliary ganglia as previously described (Chen et al., 2001) . Briefly, ganglia were treated with trypsin (0.025%, 15 min, 37°C) and CG neurons dispersed by trituration and grown on coated glass coverslips. The growth medium consisted of Eagle's minimum essential medium supplemented with 2 mM glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, and 10% heat-inactivated horse serum (MEM, all components from Invitrogen, Rockville, MD) and with freshly-prepared E17 chick eye extract (3% v/v, MEM/eye). Glass coverslips (#1, 12 mm, Fisher Scientific) were acid-washed and coated with 0.2 mg/ml poly-D-ornithine and 30 ng/ml mouse laminin (Collaborative Biomedical, Bedford, MA) . Coverslip cultures were maintained for up to 7 d in 16 mm multiwell plates at 37°C in 95% air and 5% CO2, and the culture medium replenished every 2-3 d.
Microscopy. To localize PACAP and assess its depletion, E19 ciliary ganglia were incubated (30 min, 22°C) in MEM containing normal (5 mM) or depolarizing (50 mM) KCl, and then processed using a whole ganglion imaging protocol (Rubio et al., 2005) modified to accommodate PACAP signal amplification {Tyramide signal amplification (TSA) kit, Molecular Probes/Invitrogen, Carlsbad, CA}.
Control and KCl-treated ganglia were fixed with 4% paraformaldehyde freshly prepared in 0.1 M Phosphate buffered saline (PBS, 30 min, 22°C), washed in PBS (16h, 4°C), and incubated in PBS containing 3% H2O2 (1h, 22°C) to quench endogenous peroxidase activity. Ganglia were then incubated (16h, 4°C) in block solution (PBS containing 0.1% Triton X-100, and 1% TSA kit block reagent) with
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bipolar electrodes were fabricated from theta-glass capillary tubing (TG150-4, Warner Instruments, Hamden, CT) pulled to 1-3 µm overall diameter, the barrels filled with RS, and the electrode mounted in a ported theta-glass holder (THS-F15PH, Warner Instruments, Hamden, CT) connected to an isolated stimulator (Model 2100, A-M Systems, Carlsborg, WA). Neurite fasicles were isolated by partially drawing them into the electrode barrels using gentle suction, and voltage pulses (100-300 µsec)
applied between the barrels. The stimulus intensity was adjusted to activate single axons, as determined by "minimal stimulation" criteria (e.g., further reducing stimulus intensity elicited eEPSCs in the follower neuron less than 25% of the time). We considered the criteria satisfied when stimuli were just sufficient to evoke EPSCs that (1) activated with brief constant delay, (2) activated to full amplitude without notches indicative of a secondary component, and (3) had amplitudes and kinetics matching those of sEPSCs in the same culture. Miniature EPSCs (mEPSCs) were obtained either from spontaneous synaptic events acquired while blocking Na + channel dependent action potentials with tetrodotoxin (TTX, 1 µM; is), or from unitary synaptic events isolated from amplitude histograms collected in evoked transmission assays (ie).
Spontaneous sEPSCs and mEPSCs were examined off-line using Mini Analysis (6.0.3, Synaptsoft, Fort Lee, NJ) as previously described (Chen et al., 2001; Zhou et al., 2004) . Only those events that arose abruptly and had peak amplitudes >2.5 X baseline RMS current noise (typically 1-2 pA) were selected for analysis. For each neuron, the timing and peak size of selected events were exported to Excel spreadsheets (11.5.5, Microsoft, Redmond, WA) . Average sEPSC and mEPSC frequencies (Fs and fs, Hz) were determined from the total number of events divided by the recording epoch duration (usually 2 min) while sEPSC and mEPSC amplitudes were characterized from the average of individual amplitudes (Is and is, pA). To examine the distribution of EPSC frequencies and amplitudes, Fs, fs, Is, and is values were compiled in cumulative histograms using Prism (4.0a, GraphPad, La Jolla, CA). Stimulus-evoked EPSCs were identified using PulseFit (8.66, HEKA Instruments, Bellmore, NY) using the minimal stimulation and detection criteria described above, with the added requirement that they occur with fixed synaptic delay following fasicle stimulation. While the total delay was stable for any given trial, it varied between trials (typically from ≈2-10 ms) likely because the distance between stimulating electrode and soma recording patch pipette ranged from ≈20-100 µm.
For each recording, average eEPSC amplitudes (Ie) were determined from the sum of all event amplitudes (including failures, Ie = 0) divided by the total number of applied stimuli (usually 120).
Unitary, mEPSC amplitudes (ie) were obtained by averaging event amplitudes within in the lowest component size of histograms assembled from all evoked events.
The plasma membrane nAChR population was stimulated by focally applying nicotine (Nic, 20 µM in RS) via microperfusion (7-10 psi) to CG neuron somas held at -70 mV. To ensure selective α3*-nAChR activation, the cultures were pretreated with 50 nM αBgt to block α7-nAChR for 1h as previously described (Nai et al., 2003; Zhou et al., 2004) . The resulting peak current amplitudes and slow current decay were analyzed using Clampfit (pClamp 6.0 or 8.0, Axon Instruments, Burlingame, CA) as previously described (Nai et al., 2003; Zhou et al., 2004) . Peak response amplitudes were normalized to neuron soma membrane capacitance (pA/pF), and values obtained from PACAP-treated (100 nM, 15 min) and control neurons from the same cultures compared. Tetrodotoxin (TTX, 1 µM) was included in some experiments to test the effect of action potential blockade.
To assess changes in membrane excitability associated with PACAP treatment (Braas et al., 1998; DeHaven and Cuevas, 2004) , patch pipettes were filled with 110 KMeSO4, 10 NaCl, 5 MgCl2, 0.6 EGTA, and 10 HEPES and the recording mode switched from voltage-to current-clamp after attaining the whole-cell configuration. Neurons displaying resting potential (Vrest) values >-40 mV or input resistance (Rin) values <500 MΩ were excluded. A family of 200 ms depolarizing current pulses (from 6 to 96 pA, in 6 pA steps) was applied at 0.1 Hz to initiate action potentials. Action potential numbers and inter-spike intervals were computed and analyzed as a function of the applied current for PACAPtreated and control neurons.
Drug treatments. Unless otherwise stated, all reagents were added directly to established cultures maintained in MEM/eye. Acute treatments were for 15 min prior to recording on d 5 in culture.
For washout studies, the media was replaced with MEM/eye at the end of treatment (for an additional 30 min to 48 h). When signaling pathway inhibitors were tested, the neurons were pre-treated with the inhibitor for 15 min prior to exposure to PACAP (total treatment time of 30 min). Treatment conditions included elevated KCl (addition of 45 mM KCl), PACAP38 (1-300 nM; American Peptide, Inc.,
Sunnyvale, CA), forskolin (10 µM), 8-Bromo-cyclic AMP (8Br-cAMP, 2 mM), SQ22536 (10-100 µM),
MDL12330A
(1-100 µM), H89 (10 µM), U73122 (0.1-1.0 µM), Myr-GRTGRRNAI-NH2 , 1 µM, Myristoylated Protein Kinase A Inhibitor Amide 14-22, EMD Biosciences, San Diego, CA], L-NitroArginine Methyl Ester (L-NAME, 100 µM), and sodium nitroprusside (SNP, 100 µM), either alone or in combinations, as described. Both maxadilan and Max.d.4 (PAC1 agonist and antagonist, respectively) (Moro and Lerner, 1997; Moro et al., 1999) were generously provided by E. A. Lerner (Massachusetts General Hospital, Charlestown, MA). Unless otherwise specified, the pharmacological agents were purchased from Sigma-Aldrich (St. Louis, MO). The concentrations of activators and inhibitors used were based on previous studies either by this lab or others (Margiotta and Pardi, 1995; Csernus et al., 1999; Gadea et al., 1999; McIntosh et al., 1999; Pardi and Margiotta, 1999; Kimura, 2000; Pugh and Margiotta, 2000; Kanda and Watanabe, 2001; Mohamed et al., 2001; Wang et al., 2004; Zhou et al., 2004; Pugh and Margiotta, 2006 
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
RESULTS
PACAP localization and release.
To test PACAP's potential for modulating nicotinic transmission, we first assessed its localization and voltage-dependent release in situ. In the developing CG, ciliary neurons receive 1:1 cholinergic input from accessory occulomotor neuron axons that terminate in a distinctive calyx enveloping most of the postsynaptic neuron surface (Hess, 1965; Landmesser and Pilar, 1972; Cantino and Mugnaini, 1975; Paysan et al., 2000) . Consistent with their role as presynaptic terminals, calyces are strongly immunoreactive for the presynaptic markers, SV2
(Wilson Horch and Sargent, 1995) and Synapsin I. Further, Synapsin I and PACAP immunolabeling overlap considerably ( Fig. 1A -C; MS:P ≈ MP:S ≈ 0.70), confirming that PACAP colocalizes with ACh in presynaptic terminals within the CG (Sumner et al., 2004) . Previous studies have shown that neurotransmission from calyx to ciliary neuron reliably follows stimuli delivered at frequencies up to 50
Hz (Dryer and Chiappinelli, 1985) and that 16-20 Hz stimulation is sufficient to trigger PACAP release from splanchnic nerve terminals and intercardiac nerve fibers (Tornoe et al., 2000; Lamouche and Yamaguchi, 2001; Tompkins et al., 2007) where it is a co-transmitter with ACh (Hamelink et al., 2002; Tompkins et al., 2007) . Consistent with activity-dependent PACAP release in the CG, sustained depolarization achieved by treating ciliary ganglia with RS containing 50 mM KCl (15 min) abolished PACAP immunolabeling in calyces ( Fig. 1D -F; MS:P ≈ 0.02), leaving Synapsin I immunolabeling unaffected. Together with its ability to enhance nAChR function (Margiotta and Pardi, 1995; Pardi and Margiotta, 1999) and regulate catecholamine secretion (Hamelink et al., 2002 ), PACAP's localization in and activity-dependent release from cholinergic terminals prompted us to examine its functional role in modulating nicotinic neurotransmission.
PACAP increases EPSC frequency and amplitude at nicotinic synapses on CG neurons. CG
neurons form an extensive synaptic network in culture, and by 3 d nearly all display sEPSCs (Margiotta and Berg, 1982; Chen et al., 2001) . The vast majority of sEPSCs are mediated by α3*-nAChRs since treating cultures with αCTx-MII to block α3*-nAChRs (Chen et al., 2001 ) drastically reduced both sEPSC frequency and amplitude, while blocking α7-nAChRs with  αBgt had little effect (Chen et al., 2001) . In the present studies, sEPSCs recorded from control cultures occurred at frequencies of 0.4 -
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2.0 Hz and displayed peak amplitudes of 6 -100 pA with overall mean values (Fs and Is) of 1.3 ± 0.1
Hz and 14.6 ± 0.4 pA, respectively (n = 262 neurons from 59 experiments). After 15 min application of 100 nM PACAP, overall synaptic activity increased ( Fig. 2A) , as was reflected in Fs and Is shifts to significantly larger mean values (2.5 ± 0.2 Hz and 18.6 ± 0.6 pA, respectively; n = 146) that were 3.8-(Fs*) and 1.4-(Is*) times those obtained from sham-treated control neurons (n = 154) tested in the same experiments (Fig. 2B, C) . In time course studies, PACAP was seen to induce maximal increases in Fs*
and Is* within 5 min, and its effects were sustained for up to 48 h following a single brief application ( Fig.   2D , E). Thus PACAP rapidly increases both nicotinic sEPSC frequency and amplitude, and the synaptic modulation persists long after its removal. ]in mobilization, and another requiring AC, cAMP production and subsequent PKA phosphorylation of downstream target proteins (Rawlings, 1994) . In accord with the presence of signaling competent PAC1Rs (Vaudry et al., 2000) PACAP is >10-fold more potent than VIP in stimulating both cAMP production and IP turnover in CG neurons (Margiotta and Pardi, 1995; Pardi and Margiotta, 1999) . While recent PCR experiments reveal transcripts encoding VPACR and PAC1R isoforms in CG RNA (Sumner, Pugh, and Margiotta, unpublished) only PAC1Rs that couple via AC/PKA-mediated transduction were required to enhance synaptic function. First, consistent with PAC1R involvement, PACAP potently and selectively enhanced synaptic function (Fig. 3A) . Increasing PACAP concentrations (1-100 nM) produced progressively larger values of sEPSC Fs and Is, and the nanomolar concentrations required to produce half-maximal stimulation (EC50 ≈ 5 nM for both) were indicative of high potency. In accord with PACAP-selective actions, VIP failed to significantly augment A C C E P T E D M A N U S C R I P T
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either Fs or Is when applied at 100 nM, a concentration at which PACAP produces maximal effects.
Second, although PACAP potently activates PLC-as well as AC-dependent transduction in CG neurons (Margiotta and Pardi, 1995; Pardi and Margiotta, 1999) only AC-dependent signaling was necessary to modulate nicotinic synaptic function (Fig. 3B, C) . Specifically, the ability of PACAP to increase sEPSC Fs and Is was unaffected by inhibiting PLC with U-73122, previously shown to block PACAP stimulated IP turnover and [Ca 2+ ]in mobilization in CG neurons (Pardi and Margiotta, 1999) .
Consistent with this finding, treatment with muscarine (100 µM) which activates muscarinic acetylcholine receptors and induces IP turnover in the neurons (Rathouz et al., 1995) failed to enhance sEPSC Fs and Is. By contrast, PACAP-induced increases in Fs and Is were blocked by inhibiting AC with either MDL12330A (Guellan et al., 1977) or SQ-22356, a reagent previously shown to reduce cAMP production in CG neurons by ≈80% (Margiotta and Pardi, 1995) . Consistent with AC-mediated transduction, the PACAP-induced enhancement of sEPSC Fs and Is was mimicked by 8Br-cAMP, a membrane permeable cAMP analogue previously shown to enhance nAChR responses similar to that of PACAP (Margiotta et al., 1987; Margiotta and Pardi, 1995) . Further supporting a requirement for ACand cAMP-mediated signaling, PACAP's actions on sEPSCs were also blocked by PKI(14-22), a specific PKA inhibitor (Glass et al., 1989) . This last finding indicates that, like PACAP-induced neuronal survival and nAChR upregulation (Pardi and Margiotta, 1999; Pugh and Margiotta, 2006) , synaptic modulation is based on canonical AC signaling requiring cAMP accumulation and PKA phosphorylation of downstream targets. Taken together these relative-potency and effector-dependence experiments indicate that PACAP engages PAC1Rs that efficiently couple to AC/PKA-mediated transduction to modulate synaptic function.
PACAP does not increase the excitability of CG neurons.
We considered three possible mechanisms whereby PACAP/PAC1R signaling could enhance sEPSC Fs and Is. The first was by increasing neuronal excitability, as was found in previous studies where PACAP markedly increased action potential repetitive firing in cardiac ganglion neurons by ≈5-fold, concomitant with a sustained (≈5-7 mV) depolarization (Braas et al., 1998; DeHaven and Cuevas, 2004; Tompkins et al., 2007) .
PACAP (100 nM) did depolarize CG neurons since resting potentials recorded in current-clamp mode after 5 to 15 min treatments were -48.1 ± 0.8 mV (n = 8) compared with -53.9 ± 0.4 mV (n = 8) for
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sham-treated neurons from the same cultures tested in parallel (p < 0.05, t-test). The latter values were indistinguishable from the -56.0 ± 1.0 mV mean resting potentials (p > 0. 05, n = 80, t-test) previously obtained from CG neurons in culture using sharp electrodes (Margiotta and Berg, 1982) .
Unlike cardiac ganglion neurons, however, PACAP markedly reduced the excitability of CG neurons.
As depicted in Fig Since PACAP increases sEPSC amplitude (Is, Fig. 2 ) and previous rapid agonist application studies revealed that it rapidly increases α3*-nAChR responses from acutely dissociated E14 CG neuron somas (Margiotta and Pardi, 1995; Pardi and Margiotta, 1999) tests for a postsynaptic mechanism were conducted first. mEPSCs are considered indicative of nAChRs activated at postsynaptic clusters by
ACh released from single vesicles from adjacent presynaptic terminals (Lin and Bennett, 1994; Bekkers and Stevens, 1995; Chen et al., 2001; Conroy et al., 2007) . If PACAP enhanced transmission by a mechanism involving global upregulation of all α3*-nAChRs on the neuron soma, including those at
postsynaptic sites, it would be expected to increase average mEPSC amplitude (is, quantal size) since we previously found that the vast majority of sEPSCs are sensitive to blockade by αCTx-MII and hence mediated by α3*-nAChRs (Chen et al., 2001; Nai et al., 2003) . Quantal, nAChR-mediated mEPSCs are detectable in CG neurons following action potential blockade with TTX (1 µM) and are smaller and occur at lower frequencies than impulse-dependent sEPSCs both in situ and in culture (Scott and Bennett, 1993a; Scott and Bennett, 1993b; Lin and Bennett, 1994; Ullian et al., 1997; Chen et al., 2001 ). In the present experiments, criterion mEPSCs (i.e. events with peak amplitudes at least 2.5 X baseline RMS current noise) were routinely observed after TTX treatment (Fig. 5) . The mEPSCs were quite uniform in size, since the vast majority had amplitudes that fell within one standard deviation of the overall mean value (is = 7.2 ± 0.3 pA; n = 37) both within and across a total of nine separate cultures ( Fig. 5A and B ). In addition, and as expected for quantal events, mEPSC frequency and amplitude were independent of [Ca 2+ ]out ranging from 0 to 5 mM (data not shown). Moreover, treating cultures with αBgt (50 nM, 1 h) to block α7-nAChRs, the only other nAChR subtype expressed by the neurons (Nai et al., 2003) failed to alter either mEPSC frequency or amplitude, respectively (0.59 ± 0.14 Hz and 7.6 ± 0.5 pA, n = 4), relative to untreated controls (0.70 ± 0.47 Hz and 6.5 ± 1.4 pA, n = 3) from the same experiments (p > 0.5 for both, t-test). These and previous pharmacological tests with αCTx-MII indicate that the vast majority of detectable mEPSCs are mediated by the α3*-nAChR subtype. To our surprise, mEPSCs acquired from PACAP/TTX-treated neurons were very similar to those acquired from neurons treated with TTX alone and tested in the same four experiments (Fig. 5B-D , Table 1 ). A shift to slightly higher maximal mEPSC frequencies was evident in cumulative distributions compiled for PACAP/TTX treated neurons relative to accompanying TTX-controls, but the mean fs value for these treated neurons was not measurably different from that for TTX-controls. Moreover, mEPSC amplitudes were not detectably influenced by PACAP since neither the cumulative distributions nor the mean is values for PACAP/TTX-treated and TTX-control neurons differed significantly.
We first examined whether the failure of PACAP to influence mEPSC amplitude resulted from a paradoxical failure of PACAP/PAC1R signaling to influence synaptic function. When tested in these same experiments, however, PACAP treated, TTX-naïve neurons (n = 16) displayed Fs and Is values that were 4.0 ± 0.7 times and 1.8 ± 0.2 times those of corresponding values obtained from TTX-naïve
neurons (n = 22) tested in parallel (p < 0.05 for both Fs and Is, t-test) . We next addressed the possibility that the recording setup was insufficiently sensitive to resolve 25-75% increases in quantal size necessary to account for the increase in Is. This possibility was also rejected because after changing the holding potential from -70 to -90 mV a predictable 30% increase in mEPSC amplitude was easily resolved (data not shown). Lastly, we considered that α3*-nAChR upregulation by PACAP may not occur in culture, particularly after treatment with TTX. This possibility was also eliminated since peak whole-cell α3*-nAChR current amplitudes induced by rapid nicotine microperfusion in PACAP treated neurons were ≈2.4 times larger than those of sham-treated controls, and a similar enhancement was observed when incubations and tests were conducted in the presence of TTX (Fig. 5E ). These experiments indicate that while PACAP/PAC1R signaling rapidly increases α3*-nAChR-mediated currents in CG neurons, it fails to influence quantal size. Thus postsynaptic α3*-nAChRs, responsible for the vast majority of sEPSCs and mEPSCs seen previously and here appear refractory to further regulation by exogenous PACAP.
PACAP enhances synaptic activity by increasing mean quantal content.
Having rejected postsynaptic nAChRs as targets of PACAP/PAC1R signaling relevant to synaptic modulation, we addressed the possibility that PACAP alters presynaptic function. To do so, altered ACh release was evaluated by measuring mean quantal content (m) presumed to represent the average number of presynaptic vesicles released by a single impulse (Johnston and Wu, 1995) . Initial determinations of m were based on sEPSCs and obtained from average sEPSC and mEPSC amplitudes (Is and is) using the empirical relation ms = Is/is (del Castillo and Katz, 1954; Johnston and Wu, 1995) . When calculated using Is and is values obtained from separate neurons from the same cultures, ms (2.0 ± 0.3, n =19, Table 1 ) was indistinguishable from that calculated using Is and is values compiled from individual neurons before and after TTX treatment (ms = 1.6 ± 0.1, n = 3; p > 0.5, t-test). Using the former method we calculated that PACAP treatment increased ms to ≈1.6 times that of sham treated controls from the same experiments (2.9 ± 0.3, n = 16; p < 0.01, Table 1 ). While this finding suggests that PACAP enhances nicotinic synaptic transmission by influencing presynaptic function, sEPSC-based determinations of quantal content are potentially limited by two opposing factors. First, impulse independent mEPSCs will be included, skewing the distribution of sEPSC amplitudes to lower values
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and reducing m. Second, transmission failures (where Is = 0) will be unresolved and thus not included in the overall averages, as would be appropriate (del Castillo and Katz, 1954; Johnston and Wu, 1995) , skewing overall sEPSC amplitudes to higher values and increasing m.
To circumvent these potential problems, we devised a way to evoke transmission between preand postsynaptic neuron pairs. In doing so, it was presumed that any given neuron would most likely receive direct presynaptic input from axons traveling in neurite fasicles that converge upon its soma.
Indeed, when convergent fasicles were stimulated, short-latency currents indicative of synaptic transmission evoked by single axon impulses were seen in ≈90% of target somas (n = 58 fasicles, 25 neurons), whereas stimulation of non-convergent fasicles failed to evoke such currents (Fig. 6A ). The currents induced by convergent fasicle stimulation met criteria expected for impulse-dependent, nAChR-mediated evoked EPSCs (eEPSCs). They arose with fixed delay, their brief onset and slower decay kinetics resembled those of α3*-nAChR-mediated sEPSCs (Fig. 6A,B) , their peak amplitudes were increased by hyperpolarization and reduced by depolarization, and they were reversibly abolished by blocking Na + channels with TTX or nAChRs with d-tubocurarine (data not shown).
The ability to reliably evoke transmission between CG neuron pairs allowed us to test two established methods for evaluating quantal components of transmission at individual synapses (Martin and Pilar, 1964; Johnston and Wu, 1995) . The first is empirical where me is based on the ratio of average evoked response amplitudes (Ie, including failures where Ie = 0) relative to average unitary mEPSC amplitudes (ie) collected from the same neurons (me = Ie/ie). Importantly, ie values differed from those of spontaneous event amplitudes acquired in TTX (is) by <15%, and PACAP treatment similarly failed to alter ie ( Table 1 ). The second evoked method arises from the Poisson failure prediction which assumes low release probability (p) and derives m based on the total number of delivered stimuli (NT) relative to the number failures (N0), and is given by mf = ln(NT/N0). In control experiments, values of m derived from the failure method were ≈40% of those obtained empirically, possibly because p in these studies (unknown) is not optimally suited to fulfill the Poisson approximation. Nevertheless, results obtained using either method were consistent with those obtained by analyzing sEPSCs, revealing in both cases, that PACAP selectively increases quantal content (Fig. 6, Table 1 ). While quantal content
varied considerably across cultures such that overall values of me and mf were only nominally larger for PACAP-treated neurons, PACAP did significantly increase quantal content within cultures. Thus me* and mf* values were, respectively, 1.8-and 2.7-times higher for PACAP-treated neurons relative to control neurons evaluated in the same cultures (p < 0.05 for both; Table 1 ). Similarly, daily plots of me and mf for PACAP treated versus control neurons reveal linear relationships having non-zero slopes for both that predicted 2.2-and 4.2-fold increases, respectively, in quantal content associated with PACAP treatment (Fig. 6C, D) . The increases in quantal content occurred without detectable changes in mEPSC amplitudes ( Table 1 ) indicating again that quantal size is unaffected by PACAP regulation.
Based on these findings, it is concluded that PACAP rapidly enhances nicotinic transmission parameters (sEPSC Fs and Is) by selectively altering presynaptic function, as indicated by its ability using three assays to increase mean quantal content independent of quantal size.
Nitric oxide production is required for PACAP-mediated synaptic effects. Increased quantal
content was previously found to accompany long-term potentiation at nicotinic synapses on CG neurons in situ, and both were linked to elevated NO production (Lin and Bennett, 1994) . Interestingly, PACAP stimulates production of neuronal nitric oxide synthase (nNOS), the enzyme critical for NO production (Bredt and Snyder, 1990) in pituitary gonadotrophs and dorsal root ganglion neurons and does so in a cAMP-, PKA-, and calmodulin-dependent manner (Bredt and Snyder, 1990; Bredt et al., 1992; Garrel et al., 2002) . We therefore considered the hypothesis that PACAP/PAC1R signaling enhances nicotinic synaptic function by activating NOS and subsequently increasing NO production (Fig. 7) . The first test was to determine a NOS requirement by pre-treating cultures with the NOS inhibitor L-NAME and assessing subsequent PACAP-induced modulation of synaptic function. L-NAME (100 µM, 15 min) applied alone had no effect on basal synaptic transmission, but when PACAP was applied after L-NAME treatment, it failed to increase sEPSC Fs (Fig. 7A) or Is (data not shown). Thus nNOS activity appears required for PACAP to enhance transmission at neuronal nicotinic synapses.
The second test was to determine if exogenous NO mimics the actions and mechanism of PACAP induced synaptic modulation, and this also seems to be the case. Treating cultures with the NO donor, SNP (100 µM, 15 min), rapidly increased sEPSC Fs to levels that were indistinguishable from those produced by PACAP (Fig. 7A) . Moreover, as with PACAP, the SNP-induced elevation of Fs was
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accompanied by increased quantal content. The latter conclusion was reached because SNP treatment shifted the distribution of sEPSC amplitudes to significantly larger values (Fig. 7B ) without changing the distribution of mEPSC amplitudes acquired from neurons in the same three cultures (Fig.   7C ) thereby predicting an increase in ms (= Is/is). While these results do not identify obligatory signaling steps between PACAP/PAC1, NOS/NO stimulation, and the relevant synaptic targets, they do indicate that PACAP/PAC1 signaling alters nicotinic synaptic function by mechanisms that depend on NOS activation and subsequent release of NO.
DISCUSSION
The ability of PACAP to regulate nAChR function (Margiotta and Pardi, 1995; Pardi and Margiotta, 1999; Liu et al., 2000) and its localization to ACh-containing presynaptic terminals throughout the nervous system (Holgert et al., 1996; Braas et al., 1998; Calupca et al., 2000; Tornoe et al., 2000; Locknar et al., 2002; Richardson et al., 2003; Drescher et al., 2006) suggested that PACAP signaling would influence nAChR-mediated synaptic transmission. The present findings support this view, demonstrating that PACAP immunoreactivity disappears from cholinergic terminals on CG neurons following KCl depolarization and that PACAP activates PAC1Rs and AC/PKA-dependent signaling to rapidly and persistently enhance nAChR-mediated synaptic transmission in CG cultures.
Surprisingly, however, PACAP regulated synaptic function without influencing postsynaptic nAChRs (quantal size), but instead did so by increasing ACh release from presynaptic terminals (quantal content). Moreover, this presynaptic influence was dependent on NOS and subsequent mobilization of the gaseous messenger, NO. Taken together, the findings reveal that canonical PAC1R-and NOSdependent signaling mechanisms converge to regulate presynaptic function.
Levels of PACAP increase in the CG throughout embryonic development from E8 to E20 (Pugh and Margiotta, 2006) , and cholinergic presynaptic terminal calyces that innervate ciliary neurons display intense PACAP immunoreactivity by E19 ( Fig. 1 and Sumner et al., 2004) . The subcellular distribution of PACAP within calyces is unknown, however, PACAP immunoreactivity has been localized to large dense core vesicles (80-120 nm diameter) typical for neuropeptides in presynaptic terminals providing input to hypothalamic paraventricular and spinal cord intermediolateral nucleus neurons (Chiba et al., 1996; Légrádi et al., 1997) . Two major size classes of dense core vesicles, (≈85 and ≈120 nm) have been identified in CG presynaptic terminals, with enkephalin and substance P both localizing to the smaller subclass (Erichsen et al., 1982) , and from which enkephalin release has been demonstrated (Meriney et al., 1991) . The specific vesicle class that contains PACAP and the impulse frequencies that best induce its release remain to be determined. In other autonomic preparations, however, depolarizing pulses delivered at ≈20 Hz release endogenous PACAP, and do so by a Ca and Yamaguchi, 2001; Tompkins et al., 2007) . Since orthodromic transmission to ciliary neurons occurs reliably at stimulus frequencies of 25-100 Hz (Dryer and Chiappinelli, 1985; Chang and Berg, 1999) and sustained depolarization depletes PACAP from calyces ( Fig. 1) , it seems likely that these presynaptic terminals would release both ACh and PACAP at physiological firing frequencies.
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PACAP application engages PAC1Rs on CG neurons, activating canonical AC-and PKAdependent signal cascades that rapidly and persistently increase the frequency and amplitude of sESPCs in culture (Figs. 2,3) . We initially considered two plausible mechanisms to explain PACAP's actions on nicotinic synapses. The first was that PACAP might increase the excitability of CG neurons within the culture network, as it does for other autonomic neurons (Braas et al., 1998; DeHaven and Cuevas, 2004; Tompkins et al., 2007) . This mechanism was excluded, however, because PACAP slightly raised action potential threshold and blocked repetitive firing (Fig. 4) . While neither effect has been investigated further, the higher threshold is consistent with the sustained PACAP-induced depolarization increasing resting Na + channel inactivation (Hodgkin and Huxley, 1952) . In addition, the blockade of repetitive firing may result from the ability of PACAP to elevate intracellular Ca 2+ in CG neurons (Pardi and Margiotta, 1999; Woo and Margiotta, 2007) , and thereby stimulate Ca
2+
-activated small-conductance K + channels (Power and Sah, 2008) which are known to reduce repetitive firing (Pedarzani and Stocker, 2008; Louise Faber, 2009 ). Alternatively, PACAP might reduce transient Atype potassium (KA) channel currents which can support repetitive firing (Kim et al., 2005; Sonner and Stern, 2007) particularly at the modest firing frequencies seen here (Connor and Stevens, 1971) .
Consistent with this idea, PACAP reduced both KA channel currents and subunit expression in olfactory neurons (Han and Lucero, 2005, 2006) .
The second possibility was that PACAP might increase α3*-nAChR mediated mEPSC amplitudes (i.e. quantal size). This seemed likely because we previously found that PACAP acting via PAC1Rs, AC, and PKA rapidly increased whole cell-currents mediated by somatic α3*-nAChRs (Pardi and Margiotta, 1999) and because α3*-nAChRs underlie the vast majority of sEPSCs and mEPSCs detected here (Ullian et al., 1997; Chen et al., 2001) . Surprisingly, however, PACAP failed to influence quantal size (Fig. 5, Table 1 ), and control experiments indicated this result did not arise from insufficient
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resolution, the cell culture environment, or TTX treatment. Thus α3*-nAChRs localized to the postsynaptic membrane, unlike those distributed elsewhere on the soma (Margiotta and Pardi, 1995; Pardi and Margiotta, 1999) , appear refractory to regulatory influence by exogenous PACAP.
Ultrastructural and autoradiographic studies, using toxin (N-Bgt) and antibody (mAb35) probes that recognize α3*-nAChRs, do distinguish α3*-nAChR populations on CG neurons based on their relative abundance and presence at postsynaptic versus extrasynaptic (i.e. non-and peri-synaptic) sites (Jacob et al., 1986; Loring and Zigmond, 1987; Shoop et al., 2001 ). In 5 d CG cultures, surface binding studies with these same reagents reveal ≈10 5 α3*-nAChRs per neuron (Halvorsen and Berg, 1987) , and by analyzing mAb35 and SV2 labeled confocal images, we estimate that 30% of mAb35 surface labeling is somatic and of this only 15% (corresponding to ≈4,500 α3*-nAChRs) is localized in postsynaptic clusters (i.e. immediately adjacent to SV2 labeling; J.F. Margiotta and S.J. Jayakar, unpublished). Several features may distinguish low-abundance, postsynaptic α3*-nAChRs from those distributed extrasynaptically. One is subunit stoichiometry since 80% of α3*-nAChRs are assembled from α3, α5, and β4 nAChR subunits while 20% also contain β2 subunits (Vernallis et al., 1993; Conroy and Berg, 1995) raising the possibility that different proportions of the two α3*-nAChR subtypes are present at post-versus extrasynaptic sites (see also (Sargent, 2009) . A second distinguishing feature may be the degree to which post-and extra-synaptic α3*-nAChRs associate with cytoplasmic scaffolding and/or anchoring proteins. α7-nAChRs, for example, are linked to the F-actin scaffold, and disruption of this linkage dramatically alters their function (Liu and Berg, 1999) . In addition, α3*-and α7-nAChRs on CG neurons associate with different PDZ proteins but it is not known if the α3*-nAChR association with PSD-95 is obligatory or if it can also occur without (or with different) scaffolding proteins. In the CNS, association of synaptic NMDA receptors with PSD-95 provides a platform ensuring proximity to intracellular effectors and signaling cascades critical for synaptic function (Kennedy et al., 2005) ; the same may be true for nAChRs. We recently found that A-kinase anchoring proteins (AKAPs) are required for PACAP/PAC1R PKA-dependent signaling to regulate synaptic function but not to enhance α3*-nAChR currents (Jayakar et al., 2009) . Lastly, endogenous PACAP present in CG calyces ( Fig. 1 ) and in the cultures (Sumner and Margiotta, 2008) may act locally to potentiate postsynaptic α3*-nAChRs such that exogenous PACAP has no further potentiating effect on
them. These considerations suggest that differences in subunit composition, association with scaffold and AKAP protein platforms, and prior history can influence the ways synaptic and extrasynaptic α3*-nAChRs respond to PACAP/PAC1R-triggered intracellular signaling.
Since PACAP/PAC1R signaling failed to influence quantal size, we sought to determine whether it enhanced presynaptic ACh release by increasing mean quantal content, m. Consistent with this idea was the initial observation that sEPSC amplitudes increased after PACAP treatment while mEPSC amplitudes remained unchanged, predicting a >50% increase in ms (Table 1) . Subsequent quantitative transmission studies, conducted by stimulating presynaptic axon fasicles to evoke EPSCs in target CG neuron somas, confirmed the involvement of a presynaptic mechanism (Fig. 6 ). In these studies, Table 1 ). It is unlikely that this conclusion results from misidentifying impulse failures as transmission failures. First, introducing impulse failures in a synaptic model reduced both me and mf, and did so to similar degrees (J. Margiotta, unpublished) . Second, since PACAP increases impulse threshold and lowers excitability (Fig. 4) it would be expected to increase impulse failures, biasing me and mf to lower values. Such reductions in m are opposite to what is observed. The applicability of employing the EPSC amplitude ratio and Poisson failure methods in the evoked studies is supported by the observation that while me and mf varied between experiments, they were linearly related in both control and PACAP-treated neuron pairs. Further, plotting me versus mf obtained in different experiments resulted in slopes that were indistinguishable between control and PACAP-treated neurons (2.5 versus 1.8, respectively, p>0.05, data not shown). This latter finding indicates that PACAP alters quantal content without globally perturbing synaptic function. We hypothesize that the larger sEPSC amplitudes resulting from elevated quantal content would amplify the effects of PACAP throughout the culture network, bringing each interconnected neuron closer to impulse threshold and thereby causing even greater increases in Fs, as is observed.
In exploring how PACAP/PAC1R signaling could enhance presynaptic transmitter release, we
uncovered an obligatory connection to NOS and subsequent release of the gaseous messenger, NO (Fig 7) . Consistent with our findings, PACAP stimulates NOS and increases NO production in spinal cord nerve endings of dorsal root ganglion neurons (Mabuchi et al., 2004 ) by a mechanism likely involving NOS translocation to the plasma membrane (Ohnishi et al., 2008) . In the CG system subcellular sites where PAC1Rs might couple with NOS and thereby increase NO production are unknown. Since CG neuron cultures express both PAC1Rs (this study and (Pugh and Margiotta, 2006) and NOS transcripts (Sumner and Margiotta, 2008) , PAC1Rs and NOS co-localized either in CG neuron somas or presynaptic terminals could, in principle, account for the effects observed here. Thus PAC1R-mediated NOS activation would induce NO production at either site, allowing it to influence ACh release from presynaptic terminals by retrograde or direct mechanisms, respectively, as previously demonstrated in intracellular recordings from CG neurons conducted in situ (Scott and Bennett, 1993a; Scott and Bennett, 1993b; Lin and Bennett, 1994) . In the ciliary ganglion, NOS is expressed in both neurons and presynaptic terminals (Nichol et al., 1995; Cuthbertson et al., 1999) and PAC1Rs are abundant on freshly-dissociated CG neuron somas (Margiotta and Pardi, 1995; Pardi and Margiotta, 1999; Woo and Margiotta, 2007; Sumner and Margiotta, 2008) . Since PAC1R transcripts are absent from neurons providing presynaptic input to the CG (Peeters et al., 2000) and Peeters, personal communication), however, the locus of NOS and PAC1R interaction in situ may be confined to CG neuron somas. Consistent with this constraint and with a requirement for AC/PKA-dependent processes to enhance synaptic function (Fig. 3) , PAC1R transduction via AC and PKA increases CG neuron somatic cAMP and, by the resulting enhanced α3*-and α7-nAChR-mediated currents (Margiotta and Pardi, 1995; Pardi and Margiotta, 1999) , elevates somatic Ca 2+ (Verino et al., 1992; Bertrand et al., 1993; Séguéla et al., 1993) . Both cAMP and Ca 2+ are known to stimulate NOS (Oess et al., 2006; Ohnishi et al., 2008) an action that would increase somatic NO output and thus be expected to influence presynaptic ACh release in a retrograde fashion. Interestingly, a retrograde signal regulates ACh release at nicotinic synapses in mouse sympathetic ganglia where a disruption in the α3-nAChR subunit gene abolishes synaptic transmission and α3-nAChR mediated currents (Rassadi et al., 2005) . In that case, the loss of postsynaptic activity impairs presynaptic ACh release by reducing high-affinity choline transporter (CHT) function and expression (Krishnaswamy and Cooper,
2009). Increased CHT expression could similarly underlie the enhanced synaptic function induced by PACAP in CG neuron cultures that persists for days after exposures of only minutes. Indeed, in a recent gene array study, brief PACAP exposure (15 min, followed by 6h incubation in normal culture medium) upregulated CHT transcripts to levels that were 2.1 times those of sham-treated controls (Sumner and Margiotta, 2008) . Interestingly, gene transcripts encoding choline acetyltransferase and synaptotagmin IV were similarly increased after brief PACAP exposure (Sumner and Margiotta, 2008) .
Thus PACAP rapidly upregulates the expression of transcripts encoding presynaptic proteins involved not only in choline transport, but also in ACh synthesis and release, all of which could sustain enhanced synaptic function consistent with the core findings reported here.
The actions of PACAP/PAC1R signaling on synapses are similar to nicotinic long-term potentiation (LTP) previously described in the intact CG (Scott and Bennett, 1993b) because both have a presynaptic locus and share NOS/NO dependence (Figs. 5-7). As mentioned above, PACAP is released by delivering presynaptic stimuli at ≈20 Hz in other autonomic preparations (Tornoe et al., 2000; Lamouche and Yamaguchi, 2001; Tompkins et al., 2007) . Since these frequencies are similar to the 30 Hz necessary to induce LTP in the CG (Scott and Bennett, 1993b) and are expected to release both ACh and PACAP, the subsequent PAC1R-generated signaling demonstrated here may be required for LTP. The long-lasting effects of even brief PACAP exposure ( Fig. 2 and (Sumner and Margiotta, 2008) further suggest that its release need not be sustained for the peptide to exert long term effects on neurotransmission and other critical processes. Thus PACAP's broad expression, colocalization with ACh, and its rapid-onset yet persistent effects on nAChR-mediated transmission seen here, suggest PACAP will emerge as a critical modulator of nicotinic synapses throughout the nervous system. TTX. E. PACAP treatment increases inward currents generated by plasma membrane α3*-nAChRs. In these experiments, α3*-nAChRs were isolated by pre-incubating cultures in αBgt (50 nM, 1 h) (Nai et al., 2003; Zhou et al., 2004) with toxin exposure continued throughout the indicated treatments.
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me and mf by 2.2 ± 0.5-and 4.2 ± 0.7-fold, respectively. Quantal content comparisons within experiments yielded a similar trend predicting me and mf values for PACAP treated neurons that were, respectively, 1.8 ± 0.3-and 2.7 ± 0.7-times higher than those obtained from sham treated control neurons tested in parallel (Table 1 ).
Figure 7.
PACAP enhances synaptic activity via NOS activation and NO production. A. Effects of NOS inhibition and NO production. The stimulation of sEPSC frequency (Fs*) normally seen for PACAP-treated neurons (black bar) relative to sham controls tested in parallel (white bar, n = 5 for each) was blocked after inhibiting NOS with L-NAME (100 µM, checked bar, n = 4) while L-NAME alone had no discernable effect (gray bar, n = 4). Mimicking NOS activation with the NO donor SNP (100 µM, green bar, n = 8) increased Fs to a level significantly above untreated controls (n = 8) and
indistinguishable from that achieved after PACAP treatment. Asterisks (*) indicate p < 0.05 versus Control; § indicates p < 0.05 versus PACAP treatment alone. Fs* values obtained after L-NAME treatment were indistinguishable from those obtained after control or PACAP/L-NAME treatments (p > 0.05 for both). B, C. Like PACAP, NO production increases quantal content inferred from sEPSCs.
SNP treatment (green filled boxes) significantly increased Is relative to untreated controls (open boxes; n = 8 for each), but left is unchanged relative to controls (n = 9 for each). The distribution of sEPSC amplitudes (Is, B) exhibited a significant rightward shift after SNP treatment compared to controls (2113 and 1375 events from 8 PACAP-treated and 8 control neurons, respectively, p < 0.01, KS test), while mEPSC amplitudes (is, C) remained unaltered (437 and 467 events from 9 PACAP-treated and 9
control neurons, respectively, p = 0.078, KS test) thereby predicting increased ms (= Is/is). 
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